How PSG Life Sciences Accelerates Commercial Value Creation in Private Equity-Backed Life Science Companies

How PSG Life Sciences Accelerates Commercial Value Creation in Private Equity-Backed Life Science Companies

13 Questions PE Operating Partners Ask About Commercial Value Creation in Life Science Tools, CRO/CDMO, and Diagnostics Portfolio Companies Private equity has become one of the most active sources of capital in life science tools, reagents, CRO/CDMO services, genomics...